Taiwan’s COVID Vaccine

Reporter/Provider - Yin Khvat and Asnaya Chou

class="meta mb-0">Publish Date - 2021-10-20T18:26:35Z218 views

Taiwan’s only locally produced vaccine, Medigen, faced criticism when it was approved for Emergency Use Authorization, or EUA, ahead of completing Phase III trials. In an exclusive interview with Taiwan+, Medigen’s president Charles Chen tackles the criticism head on and explains how very few COVID cases in Taiwan triggered an entirely new way of approving vaccines.

We value your privacy.

We use cookies to analyze the traffic of TaiwanPlus to improve our service. Click here to find out more about TaiwanPlus's privacy policy.

Learn more Got it

Like what you see?

Download TaiwanPlus App now!

Download